title: Integrins modulate relapse to cocaine-seeking.
abstract: Relapse to cocaine-seeking involves impairments in plasticity at glutamatergic synapses in the nucleus accumbens. Integrins are cell adhesion molecules that bind to the extracellular matrix and regulate aspects of synaptic plasticity, including glutamate receptor trafficking. To determine a role for integrins in cocaine-seeking, rats were trained to self-administer cocaine, the operant response extinguished, and cocaine-seeking induced by a conditioned cue or noncontingent cocaine injection. This cocaine self-administration protocol reduced the content of the β3 integrin subunit in postsynaptic density of the accumbens core at 24 h after the last self-administration session. However, after 3 weeks of forced abstinence plus extinction training, the level of β3 was elevated and was further regulated over 120 min during cocaine-induced drug-seeking. A small peptide ligand [arginine-glycine-aspartate (RGD)] that mimics extracellular matrix protein binding to integrins was microinjected into the accumbens core during self-administration or extinction training, or just before cocaine-reinstated drug seeking. The daily RGD injections during self-administration or just before a reinstatement session inhibited cocaine-induced drug-seeking, while RGD microinjection during extinction training was without consequence on reinstated cocaine-seeking. Daily RGD during self-administration also prevented the enduring changes in β3 levels. Finally, reduced surface expression of the GluR2 subunit of the AMPA receptor is associated with cocaine-seeking, and daily RGD microinjections during self-administration training normalized the surface expression of GluR2. Together, these data indicate that the regulation integrins may contribute to cocaine-reinstated drug-seeking, in part by promoting reduced GluR2 surface expression.
authors.affiliation: Department of Neurosciences, Medical University of South Carolina, Charleston 29425, USA.
authors.forename: Armina
authors.initials: A
authors.lastname: Wiggins
authors.forename: Rachel J
authors.initials: RJ
authors.lastname: Smith
authors.forename: Hao-Wei
authors.initials: HW
authors.lastname: Shen
authors.forename: Peter W
authors.initials: PW
authors.lastname: Kalivas
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D019921:Biotinylation; D002478:Cells, Cultured; D003042:Cocaine / Q000008:administration & dosage*; D003216:Conditioning, Operant / Q000187:drug effects*; D003342:Corpus Striatum / Q000187:drug effects / Q000502:physiology; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage*; D005108:Extinction, Psychological / Q000187:drug effects; D005786:Gene Expression Regulation / Q000187:drug effects*; D039661:Integrin beta3 / Q000378:metabolism*; D008297:Male; D008845:Microinjections / Q000379:methods; D009714:Nucleus Accumbens / Q000187:drug effects / Q000378:metabolism; D009842:Oligopeptides / Q000008:administration & dosage; D051381:Rats; D017207:Rats, Sprague-Dawley; D018091:Receptors, AMPA / Q000378:metabolism; D012054:Reinforcement, Psychology; D012646:Self Administration / Q000379:methods; D013347:Subcellular Fractions / Q000187:drug effects / Q000378:metabolism; D013997:Time Factors
chemical_list: D018765:Dopamine Uptake Inhibitors; D039661:Integrin beta3; D009842:Oligopeptides; D018091:Receptors, AMPA; C047981:arginyl-glycyl-aspartic acid; D003042:Cocaine; C104722:glutamate receptor ionotropic, AMPA 2
references.citation: Nat Neurosci. 2009 Aug;12(8):1036-41
references.pmid: 19597494
references.citation: J Neurosci. 2010 Jun 9;30(23):7984-92
references.pmid: 20534846
references.citation: Cell Tissue Res. 2001 Sep;305(3):285-98
references.pmid: 11572082
references.citation: Nature. 2008 Jul 3;454(7200):118-21
references.pmid: 18500330
references.citation: J Neurochem. 2008 Nov;107(3):679-89
references.pmid: 18702665
references.citation: Nat Rev Neurosci. 2007 Nov;8(11):844-58
references.pmid: 17948030
references.citation: J Neurosci. 2009 May 6;29(18):6007-12
references.pmid: 19420267
references.citation: J Neurosci. 2009 Mar 4;29(9):2876-84
references.pmid: 19261883
references.citation: Nat Neurosci. 2008 Mar;11(3):344-53
references.pmid: 18278040
references.citation: Annu Rev Cell Dev Biol. 1996;12:697-715
references.pmid: 8970741
references.citation: J Neurosci. 2007 Oct 10;27(41):10982-92
references.pmid: 17928439
references.citation: Neuron. 2005 Jul 21;47(2):255-66
references.pmid: 16039567
references.citation: J Neurosci. 2006 Feb 1;26(5):1579-87
references.pmid: 16452681
references.citation: J Neurosci. 2004 Aug 11;24(32):7167-73
references.pmid: 15306650
references.citation: Neuron. 2003 May 8;38(3):447-60
references.pmid: 12741991
references.citation: J Neurochem. 2003 Dec;87(6):1478-84
references.pmid: 14713303
references.citation: Psychopharmacology (Berl). 2003 Jul;168(1-2):3-20
references.pmid: 12402102
references.citation: Neuron. 2008 Jun 12;58(5):749-62
references.pmid: 18549786
references.citation: Brain Res. 2000 Apr 17;862(1-2):49-58
references.pmid: 10799668
references.citation: J Cell Biol. 2007 Sep 24;178(7):1295-307
references.pmid: 17875741
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19520-5
references.pmid: 19047646
references.citation: Br J Pharmacol. 2008 May;154(2):261-74
references.pmid: 18311189
references.citation: J Neurosci. 2009 May 13;29(19):6176-85
references.pmid: 19439595
references.citation: Brain Res Brain Res Rev. 1991 Sep-Dec;16(3):223-44
references.pmid: 1665095
references.citation: Neuron. 2008 Mar 13;57(5):719-29
references.pmid: 18341992
references.citation: Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5579-84
references.pmid: 16567651
references.citation: J Neurosci Methods. 1980 Dec;3(2):129-49
references.pmid: 6110810
references.citation: J Cell Biol. 2005 May 9;169(3):515-26
references.pmid: 15866889
references.citation: Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4321-6
references.pmid: 10760299
references.citation: Neuron Glia Biol. 2008 Aug;4(3):179-87
references.pmid: 19758485
references.citation: J Neurosci. 2007 Sep 26;27(39):10621-35
references.pmid: 17898233
references.citation: J Biol Chem. 2003 Mar 21;278(12):10722-30
references.pmid: 12524441
references.citation: Adv Exp Med Biol. 2010;674:95-105
references.pmid: 20549943
references.citation: Neuron Glia Biol. 2008 Aug;4(3):165-7
references.pmid: 19811704
references.citation: Nat Rev Neurosci. 2009 Aug;10(8):561-72
references.pmid: 19571793
references.citation: J Proteome Res. 2008 Apr;7(4):1740-9
references.pmid: 18327965
references.citation: Nat Rev Neurosci. 2008 May;9(5):344-56
references.pmid: 18425089
references.citation: Curr Opin Cell Biol. 2000 Apr;12(2):250-6
references.pmid: 10712922
references.citation: Nat Rev Cancer. 2005 Jan;5(1):51-63
references.pmid: 15630415
references.citation: Nat Neurosci. 2006 Jul;9(7):868-9
references.pmid: 16732275
references.citation: Science. 1999 Aug 13;285(5430):1028-32
references.pmid: 10446041
references.citation: Nat Neurosci. 2009 Feb;12(2):182-9
references.pmid: 19136971
references.citation: Int Rev Cell Mol Biol. 2010;279:135-90
references.pmid: 20797679
references.citation: Am J Psychiatry. 1976 Jun;133(6):627-34
references.pmid: 776007
references.citation: J Neurosci. 2005 Jun 29;25(26):6105-18
references.pmid: 15987940
references.citation: Neuropharmacology. 2004;47 Suppl 1:33-46
references.pmid: 15464124
references.citation: J Neurosci. 2003 Aug 6;23(18):7107-16
references.pmid: 12904471
references.citation: Neuron. 2004 Feb 19;41(4):625-38
references.pmid: 14980210
references.citation: Nature. 2003 Jan 2;421(6918):70-5
references.pmid: 12511956
references.citation: Nat Rev Cancer. 2010 Jan;10(1):9-22
references.pmid: 20029421
references.citation: Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16859-64
references.pmid: 19805386
references.citation: Learn Mem. 2007 Mar 09;14(3):214-23
references.pmid: 17353546
references.citation: Neuropsychopharmacology. 2007 Feb;32(2):377-87
references.pmid: 16794574
references.citation: Immunol Lett. 1996 Dec;54(2-3):189-93
references.pmid: 9052876
references.citation: J Neurosci. 2006 Jan 4;26(1):223-32
references.pmid: 16399691
references.citation: J Neurosci. 2006 Feb 8;26(6):1813-22
references.pmid: 16467530
references.citation: Nature. 1984 May 3-9;309(5963):30-3
references.pmid: 6325925
references.citation: J Mol Neurosci. 2010 Mar;40(3):284-94
references.pmid: 19629758
references.citation: J Neurochem. 1999 Jun;72(6):2397-403
references.pmid: 10349849
references.citation: J Neurosci. 2008 Oct 22;28(43):11061-70
references.pmid: 18945913
references.citation: Prog Neurobiol. 1998 Apr;54(6):679-720
references.pmid: 9560846